Keystone Capital Management Launches Gillson Sciences to Advance Human Health Through Scientific Excellence

Keystone Capital Management has announced the creation of Gillson Sciences, a company dedicated to providing laboratory testing, monitoring, and advisory solutions aimed at ensuring quality, compliance, and regulatory excellence for its clients. This initiative is set to offer science-driven support to industries involved in the development, sourcing, manufacturing, and commercialization of safe and effective products. With a strong foundation in pharmaceuticals, biopharma, medical devices, healthcare, and environmental sciences, Gillson Sciences is poised to tackle a wide array of human health challenges.

The formation of Gillson Sciences in January 2025 was achieved through the acquisitions of Azzur Labs, now known as Gillson Testing, and Micro Measurement Laboratories (MML). This strategic move combines the expertise of two leading entities in their fields, enabling Gillson to offer more comprehensive and integrated scientific solutions. The company operates laboratories in Pennsylvania, Illinois, and California, with a team of field personnel spread across the United States.

Jason Fischer, with a notable 13-year tenure at UL Solutions, has been appointed CEO of Gillson Sciences. Fischer's extensive experience in corporate development and leadership roles positions him as a key figure in driving the company's growth and expansion. Under his guidance, Gillson Sciences aims to become a market leader in testing, monitoring, and advisory solutions focused on advancing human health.

Gillson Sciences is committed to exploring opportunities to broaden its capabilities within the testing, inspection, certification, and compliance (TICC) sector. The company's mission is to partner with organizations that share its dedication to advancing quality, safety, and regulatory excellence across critical markets. For more information, visit https://GILLSONSCIENCES.com.

The establishment of Gillson Sciences marks a significant step forward in the pursuit of scientific excellence and regulatory compliance in industries critical to human health. With a clear vision and a strong leadership team, the company is well-positioned to make a lasting impact in its field.